Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Everything Worth Reading.
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
GlobeNewswire, Inc.
·
May 16, 2025
Company intends to provide an interim read out by the end of summer 2025 Top-line results anticipated in Q4 2025; study on track to support U.S. pivotal trial initiation in 2026 BERKELEY, Calif. and MAINZ, Germany, May 16, 2025 (GLOBE NEWSWIRE) --...
LAIKA Live Action Taps Captain Marvel Filmmakers Anna Boden & Ryan Fleck to Bring #1 NY Times Bestselling Author Taylor Jenkins Reid’s Upcoming Novel Atmosphere to the Screen
Business Wire
·
May 15, 2025
LAIKA has tapped filmmakers Anna Boden & Ryan Fleck (Captain Marvel, Masters of the Air) to adapt and direct a live action film based on the novel Atmosphere (Pub 6/3/25; Ballantine Books) by #1 NYT bestselling author Taylor Jenkins Reid (Daisy...
Thrilling Supernatural Adventure Uncovered in William J. Davis’ Latest Novel, Anchor’s Road
EIN Presswire
·
May 15, 2025
NEW YORK, NY, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Woodbridge Publishers returns with Anchor’s Road, a gripping supernatural thriller that blends historical intrigue with non-stop action by William J. Davis. Following the success of...
Literature, Publishing, and Translation Commission Concludes Riyadh’s Role at Buenos Aires International Book Fair 2025
EIN Presswire
·
May 14, 2025
Riyadh, Guest of Honor at the 49th Buenos Aires Book Fair, highlighted Saudi culture with seminars, performances & translation initiatives under Vision 2030. RIYADH, SAUDI ARABIA, May 14, 2025 /EINPresswire.com/ -- The Literature, Publishing,...
Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome
Business Wire
·
May 15, 2025
Quiver Bioscience (“Quiver”) and QurAlis Corporation (“QurAlis”), today announced that the companies have entered into a research collaboration to advance a novel gene-targeted therapeutic approach for the treatment of Fragile X syndrome (FXS)....
Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA
Business Wire
·
May 15, 2025
Gilead Sciences, Inc. (Nasdaq: GILD) will present more than 20 abstracts across both Gilead and Kite at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting May 30 – June 3 and the 2025 European Hematology Association...
Inspiring and Heartwarming Picture Book Turns Stage Fright into Magic
EIN Presswire
·
May 14, 2025
JASON’S MAGICAL BUTTERFLIES by Somone Grier PATERSON, NJ, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- In her debut children's book, JASON’S MAGICAL BUTTERFLIES, author Somone Grier introduces young readers to Jason, a budding magician who...
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1
Business Wire
·
May 14, 2025
Takeda (TSE: 4502/NYSE:TAK) today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2...
Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease
GlobeNewswire, Inc.
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal...
Agendia to Unveil Novel Data on Genomic Risk and Treatment Disparities in Early-Stage Breast Cancer at 2025 ASCO® Annual Meeting
Business Wire
·
May 15, 2025
Agendia®, Inc., announced today that new data on its comprehensive genomic tests will be presented at the American Society of Clinical Oncology Annual Meeting (ASCO), taking place May 30th – June 3rd, 2025, in Chicago, Illinois. The selected...
BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
GlobeNewswire, Inc.
·
May 15, 2025
Despite growing recognition of long COVID as a serious condition, diagnosed patients have no approved treatment options, with many suffering from debilitating fatigue and brain fog Evidence suggests sustained inflammation plays a central role in...
Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness
Business Wire
·
May 15, 2025
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a novel...
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
GlobeNewswire, Inc.
·
May 15, 2025
LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data...
St. Paul Author Honored as Midwest Book Awards Finalist for 'It’s About Time' (Millions of Copies Sold for Dad)
EIN Presswire
·
May 13, 2025
A Former Minnesota Amateur boxing champions autobiography reads like a novel wrapped around a package of poems ST PAUL, MN, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- Former Minnesota amateur boxing champion and author Mark Connor, from...
Atticus Publishing proudly present, 'Love and Karaoke' by C.S. Zen
EIN Presswire
·
May 14, 2025
Finding Love One Song at a Time: A Heartfelt Journey of Music, Courage, and Connection in Love And Karaoke CA, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- American author and educator C.S. Zen (pen name of Christopher Ratcliff) delivers a...
Taeler Hendrix Unveils Haunting Debut Novel: Behind These Whispering Walls
EIN Presswire
·
May 15, 2025
From Wrestling Rings to Gothic Realms—A Tale of Trauma, Memory, and the Supernatural BOSTON, MA, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Renowned professional wrestler and dynamic storyteller Taeler Hendrix steps into the literary...
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience
Business Wire
·
May 15, 2025
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the...
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
GlobeNewswire, Inc.
·
May 14, 2025
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients...
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
Business Wire
·
May 14, 2025
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under...
ROBERTO SCHIRALDI UNPACKS THE DESTRUCTIVE LEGACY OF MACHO-ISM AND OPENS A PATH TO HEALING
EIN Presswire
·
June 4, 2025
Author Roberto Schiraldi confronts a complex age-old phenomenon of gender perceptions through his groundbreaking literary work. TORONTO, ONTARIO, CANADA, June 4, 2025 /EINPresswire.com/ -- In a striking and profoundly personal new release, “Post...